// App-Quantinova.ai

427 : Interleukin‐13 Activated Hedgehog Signaling Regulates Pathogen Driven Inflammation and Fibrosis

Researchers

Presenter

  • Thiago A. Pereira

Principal Investigators

  • Lee Borthwick

  • Mariana Machado

  • Paula Vidigal

  • Izabela Voieta

  • Vivian Resende

  • Jessica Bonzo

  • Joseph R. Arron

  • Rafal P. Witek

  • Jos R. Lambertucci

  • Anna Mae Diehl

  • Thomas A. Wynn

Medical Centers

  • Immunopathogenesis section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Washington, DC

  • Division of Cellular Therapy, Duke University Medical Center, Durham, NC

  • Hospital de Santa Maria, Lisbon, Portugal

  • Faculdade de Medicina-Universidade Federal de Minas Gerais, Belo Horizonte-Minas Gerais, Brazil

  • Thermo Fisher Scientific, Frederick, MD

  • Genentech, San Francisco, CA

  • Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom

Locations

  • United States

  • Portugal

  • Brazil

  • United Kingdom

Companies

  • Genentech, Inc.

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Portal Hypertension

Biomarkers

  • Interleukin 13

Drug/Treatment

  • Interleukin

  • Mofezolac

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved